In sunitinib-resistant RCC cells, the expression of TRAF1 can be effectively suppressed by regulating METTL14, thereby inhibiting the angiogenesis signaling pathway and activating the apoptosis signaling pathway (128). Here, TRAF1 is linked to renal cell carcinoma.